Endothelium-dependent relaxation to poly-L-arginine in canine coronary arteries

Endothelium: Journal of Endothelial Cell Research

Volumn 10, Issue 2, 2003, Pages 79-87

  Rodrigues, Alfredo J ^a,b   Evora, Paulo R B ^a,b   Pearson, Paul J ^a   Schaff, Hartzell V ^a  

^a MAYO CLINIC   (United States)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Cationic proteins; Coronary artery; EDHF; EDRF; Endothelium dependent relaxation; Endothelium derived hyperpolarizing factor; Poly L arginine; Polycations

Indexed keywords

APAMIN; CALMIDAZOLIUM; CHARYBDOTOXIN; GLIBENCLAMIDE; INDOMETACIN; MEPACRINE; N(G) NITROARGININE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE INHIBITOR; OUABAIN; OXYHEMOGLOBIN; PHOSPHOLIPASE A2; POLYARGININE; POTASSIUM CHLORIDE; PROSTACYCLIN; PROSTAGLANDIN F2 ALPHA; PROSTAGLANDIN SYNTHASE;

ANIMAL TISSUE; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CORONARY ARTERY CONSTRICTION; CORONARY ARTERY DILATATION; DOG; DRUG ANTAGONISM; DRUG EXPOSURE; ENDOTHELIUM; FEMALE; HYPERPOLARIZATION; IN VITRO STUDY; INCUBATION TIME; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN SECRETION; SIGNAL TRANSDUCTION; VASCULAR SMOOTH MUSCLE;

ACETYLCHOLINE; ANIMALS; CORONARY VESSELS; DOGS; ENDOTHELIUM, VASCULAR; GLYBURIDE; INDOMETHACIN; MUSCLE RELAXATION; NITRIC OXIDE SYNTHASE; OUABAIN; OXYHEMOGLOBINS; PEPTIDES; VASODILATION;

ANIMALIA; CANIS FAMILIARIS; STROPHANTHUS GRATUS;

EID: 0041564108     PISSN: 10623329     EISSN: None     Source Type: Journal    
DOI: 10.1080/10623320303367     Document Type: Article

References (38)

1. Adeagbo A.S. (1997) Endothelium-derived hyperpolarizing factor: Characterization as a cytochrome P450 1A-linked metabolite of arachidonic acid in perfused rat mesenteric prearteriolar bed. American Journal of Hypertension, 10, 763-771.
2. Alavi N. (1990) Effect of polycations on prostaglandin synthesis in cultured glomerular mesangial cells. Biochimica Biophysica Acta, 1042, 221-226.
3. Baron A., Frieden M., and Beny J.L. (1997) Epoxyeicosatrienoic acids activate a high-conductance, Ca(2+)-dependent K+ channel on pig coronary artery endothelial cells. Journal of Physiology, 504, 537-543.
4. Bauersachs J., Hecker M., and Busse R. (1994) Display of the characteristics of endothelium-derived hyperpolarizing factor by a cytochrome P450-derived arachidonic acid metabolite in the coronary microcirculation. British Journal of Pharmacology, 113, 1548-1553.
5. Brayden J.E. (1996) Potassium channels in vascular smooth muscle. Clinical and Experimental Pharmacology and Physiology, 23, 1069-1076.
6. Busse R., Edwards G., Félétou M., Fleming I., Vanhoutte P.M., and Arthur Weston A.H. (2002) EDHF: Bringing the concepts together. Trends in Pharmacological Sciences, 23, 374-380.
7. Chen G., and Suzuki H. (1989) Some electrical properties of the endothelium-dependent hyperpolarization recorded from rat arterial smooth muscle cells. Journal of Physiology, 410, 91-106.
8. Coyle A.J., Uchida D., Ackerman S.J., Mitzner W., and Irvin C.G. (1994) Role of cationic proteins in the airway. Hyperresponsiveness due to airway inflammation. American Journal of Respiratory and Critical Care Medicine, 150, S63-S71.
9. David-Dufilho M., Brunet A., Privat C., and Devynck M.A. (2002) Quinacrine increases endothelial nitric oxide release: Role of superoxide anion. European Journal of Pharmacology, 436, 159-163.
10. Dhein S., Hartmann E., Salameh A., and Klaus W. (1997) Characterization of a peptide endothelium-derived constricting factor EDCF. Pharmacological Research, 35, 43-50.
11. Eckman D., Hopkins N., McBride C., and Keef K. (1998) Endothelium-dependent relaxation and hyperpolarization in guinea-pig coronary artery: Role of epoxyeicosatrienoic acid. British Journal of Pharmacology, 124, 181-189.
12. Evora P.R., Pearson P.J., and Schaff H.V. (1994) Impaired endothelium-dependent relaxation after coronary reperfusion injury: Evidence for G-protein dysfunction. Annals of Thoracic Surgery, 57, 1550-1556.
13. Feletou M., and Vanhoutee P.M. (1988) Endothelium-dependent hyperpolarization of canine coronary smooth muscle. British Journal of Pharmacology, 93, 515-524.
14. Félétou M., and Vanhoutte P.M. (1999) Endothelium-derived hyperpolarizing factor. Drug News and Perspectives, 28, 217-222.
15. Fisslthaler B., Fleming I., and Busse R. (2000) EDHF: A cytochrome P450 metabolite in coronary arteries. Seminars in Perinatology, 24, 15-19.
16. Fleming I. (2000) Cytochrome P450 2C is an EDHF synthase in coronary arteries. Trends in Cardiovascular Medicine, 10, 166-170.
17. Fujioka H., Ayajiki K., Shinozaki K., Toda N., and Okamura T. (2002) Mechanisms underlying endothelium-dependent, nitric oxide- and prostanoid-independent relaxation in monkey and dog coronary arteries. Naunyn Schmiedebergs Archives of Pharmacology, 366, 488-495.
18. Garland C.J., Plane F., Kemp B.K., and Cocks T.M. (1995) Endothelium-dependent hyperpolarization: A role in the control of vascular tone. Trends in Pharmacological Sciences, 16, 23-30.
19. Ge Z.D., Zhang X.H., Fung P.C., and He G.W. (2000) Endothelium-dependent hyperpolarization and relaxation resistance to N(G)-nitro-L-arginine and indomethacin in coronary circulation. Cardiovascular Research, 46, 547-556.
20. Gillespie J.S., and Sheng H. (1988) Influence of haemoglobin and erythrocytes on the effects of EDRF, a smooth muscle inhibitory factor, and nitric oxide on vascular and non-vascular smooth muscle. British Journal of Pharmacology, 95, 1151-1156.
21. Ginsburg I. (1989) Cationic polyelectrolytes: Potent opsonic agents which activate the respiratory burst in leukocytes. Free Radical Research Communications, 8, 11-26.
22. 2+-activated K+ channels in porcine coronary artery smooth muscle cells. Journal of Cardiovascular Pharmacology, 32, 642-649.
23. Hyslop S., and De Nucci G. (1993) Heparin, polycations, and atherosclerosis. Seminars in Thrombosis and Hemostasis, 19, 89-98.
24. Ignarro L.J., Gold M.E., Buga G.M., Byrns R.E., Wood K.S., Chaudhuri G., and Frank G. (1989) Basic polyamino acids rich in arginine, lysine, or ornithine cause both enhancement of and refractoriness to formation of endothelium-derived nitric oxide in pulmonary artery and vein. Circulation Research, 64, 315-329.
25. Illiano S., Nagao T., and Vanhoutte P.M. (1992) Calmidazolium, a calmodulin inhibitor, inhibits endothelium-dependent relaxations resistant to nitro-L-arginine in the canine coronary artery. British Journal of Pharmacology, 107, 387-392.
26. Kinoshita H., and Katusic Z.S. (1997) Nitric oxide and effects of cationic polypeptides in canine cerebral arteries. Journal of Cerebral Blood Flow and Metabolism, 17, 470-480.
27. Needham L., Hellewell P.G., Williams T.J., and Gordon J.L. (1988) Endothelial functional responses and increased vascular permeability induced by polycations. Laboratory Investigation, 59, 538-548.
28. Quilley J., Fulton D., and McGiff J.C. (1997) Hyperpolarizing factors. Biochemical Pharmacology, 54, 1059-1070.
29. Shier W.T., Dubourdieu D.J., and Durkin J.P. (1984) Polycations as prostaglandin synthesis inducers. Stimulation of arachidonic acid release and prostaglandin synthesis in cultured fibroblasts by poly(L-lysine) and other synthetic polycations. Biochemical Biophysica Acta, 793, 238-250.
30. Southan G.J., and Szabo C. (1996) Selective pharmacological inhibition of distinct nitric oxide synthase isoforms. Biochemical Pharmacology, 51, 383-394.
31. Thomas G., Hecker M., and Ramwell P.W. (1989) Vascular activity of polycations and basic amino acids: L-Arginine does not specifically elicit endothelium-dependent relaxation. Biochemical and Biophysical Research Communications, 158, 177-180.
32. Vanheel B., and Van De Voorde J. (2000) EDHF and residual NO: Different factors. Cardiovascular Research, 46, 370-375.
33. Vanhoutte P., and Félétiu M. (1996) Endothelium-derived hyperpolarizing factor. In Conclusion: Existence of Multiple Endothelium-Derived Hyperpolarizing Factor(s)? (ed. P. Vanhoutte), Harwood Academic Publishers, New York, pp. 303-305.
34. Vepa S., Scribner W.M., and Natarajan V. (1997) Activation of endothelial cell phospholipase D by polycations. American Journal of Physiology, 272,L608-L613.
35. Waldron G.J., and Cole W.C. (1999) Activation of vascular smooth muscle K+ channels by endothelium-derived relaxing factors. Clinical and Experimental Pharmacology and Physiology, 26, 180-184.
36. Westergren I., and Johansson B.B. (1993) Altering the blood-brain barrier in the rat by intracarotid infusion of polycations: A comparison between protamine, poly-L-lysine and poly-L-arginine. Acta Physiological Scandinavica, 149, 99-104.
37. Yamanaka A., Ishikawa T., and Goto K. (1998) Characterization of endothelium-dependent relaxation independent of NO and prostaglandins in guinea pig coronary artery. Journal of Pharmacology and Experimental Therapeutics, 285, 480-489.
38. Zink M.H., Oltman C.L., Lu T., Katakam P.V.G., Kaduce T.L., Lee H.-C., Dellsperger K.C., Spector A.A., Myers P.R., and Weintraub N.L. (2001) 12-Lipoxygenase in porcine coronary microcirculation: Implications for coronary vasoregulation. American Journal of Physiology, 280, H693-H704.